An Observational Analytical Molecular Neuropharmacological Research Study and a Descriptive Systematic Review on the Pharmacogenomic Mechanisms of Brain Organoids

{"title":"An Observational Analytical Molecular Neuropharmacological Research Study and a Descriptive Systematic Review on the Pharmacogenomic Mechanisms of Brain Organoids","authors":"","doi":"10.37745/ijphpp.15/vol10n3pp1421","DOIUrl":null,"url":null,"abstract":"Brain organoids recapitulate in vitro the specific stages of in vivo human brain development, thus offering an innovative tool by which to model human neurodevelopmental disease. Brain organoids can model congenital structural deficits or be subjected to environmental insult. This clinical research and systematic review was conducted for systematically exploring the molecular neuropharmacological and pharmacogenomic mechanisms of the brain organoids, with thorough explanations and analysis of the medical study literature and evidences compiled from the innumerous studies conducted, which explained the multi-dimensional pharmacomolecular significance of brain organoids. The objectives of this study were an observational analytical molecular neuropharmacological research study and a descriptive systematic review on the pharmacogenomic mechanisms of brain organoids.The mixed-method study was conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) Statement and Guidelines, 2009, described by the Cochrane Collaboration in June, 2016. At first, the steps of identification included the records which were identified through database searching and the additional records which were identified through other sources. This led to the steps of screening, which included the screened records after the duplicates were removed. From these screened records, few records were excluded, as per the exclusion criteria. Then, in the eligibility step, the full text articles were assessed for eligibility, from which few full text articles were excluded, according to the exclusion criteria, with adequate reasons. This led to the final inclusion step, where the studies were included in the qualitative synthesis of a systematic review, according to the inclusion criteria, and ultimately the studies were included in the quantitative synthesis. An observational analytical molecular neuropharmacological research study was also conducted. In this mixed-method study, the systematic review contributed 3086 refined and relevant medical records, among total 5612 records obtained from the study databases search. It also describes the molecular neuropharmacological and pharmacogenomic mechanisms of brain organoids, which elaborated this descriptive systematic review and observational analytical molecular pharmacological research study. To conclude, this clinical research and systematic review study provided the refined qualitatively synthesised medical records, study literature and databases, as well as a descriptive analysis on the pharmacogenomic mechanisms of brain organoids.","PeriodicalId":352669,"journal":{"name":"nternational Journal of Public Health, Pharmacy and Pharmacology","volume":"67 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"nternational Journal of Public Health, Pharmacy and Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37745/ijphpp.15/vol10n3pp1421","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Brain organoids recapitulate in vitro the specific stages of in vivo human brain development, thus offering an innovative tool by which to model human neurodevelopmental disease. Brain organoids can model congenital structural deficits or be subjected to environmental insult. This clinical research and systematic review was conducted for systematically exploring the molecular neuropharmacological and pharmacogenomic mechanisms of the brain organoids, with thorough explanations and analysis of the medical study literature and evidences compiled from the innumerous studies conducted, which explained the multi-dimensional pharmacomolecular significance of brain organoids. The objectives of this study were an observational analytical molecular neuropharmacological research study and a descriptive systematic review on the pharmacogenomic mechanisms of brain organoids.The mixed-method study was conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) Statement and Guidelines, 2009, described by the Cochrane Collaboration in June, 2016. At first, the steps of identification included the records which were identified through database searching and the additional records which were identified through other sources. This led to the steps of screening, which included the screened records after the duplicates were removed. From these screened records, few records were excluded, as per the exclusion criteria. Then, in the eligibility step, the full text articles were assessed for eligibility, from which few full text articles were excluded, according to the exclusion criteria, with adequate reasons. This led to the final inclusion step, where the studies were included in the qualitative synthesis of a systematic review, according to the inclusion criteria, and ultimately the studies were included in the quantitative synthesis. An observational analytical molecular neuropharmacological research study was also conducted. In this mixed-method study, the systematic review contributed 3086 refined and relevant medical records, among total 5612 records obtained from the study databases search. It also describes the molecular neuropharmacological and pharmacogenomic mechanisms of brain organoids, which elaborated this descriptive systematic review and observational analytical molecular pharmacological research study. To conclude, this clinical research and systematic review study provided the refined qualitatively synthesised medical records, study literature and databases, as well as a descriptive analysis on the pharmacogenomic mechanisms of brain organoids.
脑类器官药物基因组学机制的观察性分析分子神经药理学研究及描述性系统综述
脑类器官在体外概括了人类大脑在体内发育的特定阶段,从而提供了一种创新的工具,通过它来模拟人类神经发育疾病。脑类器官可以模拟先天性结构缺陷或遭受环境损害。本临床研究和系统综述旨在系统探索类脑器官的分子神经药理学和药物基因组学机制,并对大量医学研究文献和证据进行了深入的解释和分析,解释了类脑器官的多维药理学意义。本研究的目的是对脑类器官的药物基因组学机制进行观察性分析性分子神经药理学研究和描述性系统综述。混合方法研究按照2009年PRISMA(系统评价和荟萃分析首选报告项目)声明和指南进行,该声明和指南由Cochrane Collaboration于2016年6月描述。首先,识别步骤包括通过数据库检索识别的记录和通过其他来源识别的附加记录。这导致筛选步骤,其中包括删除重复项后筛选的记录。根据排除标准,从这些筛选的记录中,很少有记录被排除在外。然后,在资格步骤中,对全文文章的资格进行评估,根据排除标准,有充分的理由将少数全文文章排除在外。这导致了最后的纳入步骤,根据纳入标准,研究被纳入系统评价的定性综合,最终研究被纳入定量综合。还进行了观察性分析分子神经药理学研究。在这项混合方法的研究中,系统评价贡献了3086份精炼和相关的医疗记录,其中从研究数据库检索获得了5612份记录。介绍了脑类器官的分子神经药理学和药物基因组学机制,阐述了本研究的描述性系统综述和观察性分析分子药理学研究。总之,本临床研究和系统评价研究提供了精细的定性综合病历、研究文献和数据库,并对脑类器官的药物基因组机制进行了描述性分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书